Suppression of ongoing experimental allergic encephalomyelitis (EAE) in Lewis rats: Synergistic effects of myelin basic protein (MBP) peptide 68-86 and IL-4

Clinical and Experimental Immunology

Volumn 120, Issue 3, 2000, Pages 526-531

  Xu, L Y ^a   Huang, Y M ^a   Yang, J S ^a   Van Der Meide, P H ^b   Link, H ^a   Xiao, B G ^a,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UTRECHT UNIVERSITY   (Netherlands)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Autoimmunity; Experimental allergic encephalomyelitis; IL 4; Mucosal tolerance; Treatment

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; MYELIN BASIC PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; DISEASE ASSOCIATION; DRUG POTENTIATION; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; RAT; SCORING SYSTEM; WEIGHT REDUCTION;

ADMINISTRATION, INTRANASAL; AMINO ACID SEQUENCE; ANIMALS; CATTLE; CYTOKINES; DRUG SYNERGISM; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; EPITOPES; GUINEA PIGS; IN SITU HYBRIDIZATION; INTERLEUKIN-4; MOLECULAR SEQUENCE DATA; MYELIN BASIC PROTEINS; PEPTIDE FRAGMENTS; RATS; RATS, INBRED LEW; RNA, MESSENGER; TH1 CELLS; TH2 CELLS;

EID: 0034121087     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2000.01233.x     Document Type: Article

References (23)

1. 1 Wu HY, Russell MW. Nasal lymphoid tissue, intranasal immunization, and compartmentalization of the common mucosal immune system. Immunol Res 1997; 16:187-201.
2. 2 Wraith DC. Antigen-specific immunotherapy of autoimmune disease: a commentary. Clin Exp Immunol 1996; 103:349-52.
3. 3 Xiao BG, Link H. Mucosal tolerance: a two-edged sword to prevent and treat autoimmune diseases. Clin Immunol Immunopathol 1997; 85:119-28.
4. 4 Bai XF, Li HL, Shi FD, Liu JQ, Xiao BG, Van der Meide PH, Link H. Complexities of applying nasal tolerance induction as a therapy for ongoing relapsing experimental autoimmune encephalomyelitis (EAE) in DA rats. Clin Exp Immunol 1998; 111:205-10.
5. 5 Shi FD, Bai XF, Li HL, Huang YM, Van der Meide PH, Link H. Nasal tolerance in experimental autoimmune myasthenia gravis (EAMG): induction of protective tolerance in primed animals. Clin Exp Immunol 1998; 111:506-12.
6. 6 Liu JQ, Bai XF, Shi FD, Xiao BG, Li HL, Levi M, Mustafa M, Wahren B, Link H. Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99. Int Immunol 1998; 10:1139-48.
7. 7 Anderton SM, Wraith DC. Hierarchy in the ability of T cell epitopes to induce peripheral tolerance to antigens from myelin. Eur J Immunol 1998; 28:1251-61.
8. 8 Rocken M, Racke M, Shevach EM. IL-4-induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease. Immunol Today 1996; 17:225-31.
9. 9 Seder RA, Paul WE. Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu Rev Immunol 1994; 12:635-73.
10. 10 LeGros G, Ben-Sasson SZ, Seder RA, Finkelman FD, Paul WE. Generation of interleukin 4 (IL-4) producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4 producing cells. J Exp Med 1990; 172:921-9.
11. 11 Seder RA, Marth T, Sieve MC, Strober W, Letterio JJ, Roberts AB, Kelsall B. Factors involved in the differentiation of TGF-beta-producing cells from naive CD4+ T cells: IL-4 and IFN-gamma have opposing effects, while TGF-beta positively regulates its own production. J Immunol 1998; 160:5719-28.
12. 12 Inobe J, Slavin AJ, Komagata Y, Chen Y, Liu L, Weiner HL. IL-4 is a differentiation factor for transforming growth factor-beta secreting Th3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis. Eur J Immunol 1998; 28:2780-90.
13. 13 Xu L, Huang YM, Yang J, Van Der Meide PH, Levi M, Wahren B, Link H, Xiao BG. Dendritic cell-derived nitric oxide is involved in IL-4-induced suppression of experimental allergic encephalomyelitis (EAE) in Lewis rats. Clin Exp Immunol 1999; 118:115-21.
14. 14 Volpert OV, Fong T, Koch AE, Peterson JD, Waltenbaugh C, Tepper RI, Bouck NP. Inhibition of angiogenesis by interleukin 4. J Exp Med 1998; 188:1039-46.
15. 15 Holmdahl R, Moran T, Andersson M. A rapid and efficient immunization protocol for production of monoclonal antibodies reactive with autoantigens. J Immunol Methods 1985; 83:379-84.
16. 16 Link H, Olsson O, Sun J et al. Acetylcholine receptor-reactive T and B cells in myasthenia gravis and controls. J Clin Invest 1991; 87:2191-5.
17. 17 Link J, Fredrikson S, Soderstrom M, Olsson T, Hojeberg B, Ljungdahl A, Link H. Organ-specific autoantigens induce transforming growth factor-beta mRNA expression in mononuclear cells in multiple sclerosis and myasthenia gravis. Ann Neurol 1994; 35:197-203.
18. 18 Ma CG, Zhang GX, Xiao BG, Wang ZY, Link J, Olsson T, Link H. Mucosal tolerance to experimental autoimmune myasthenia gravis is associated with down-regulation of AChR-specific IFN-gamma-expressing Th1-like cells and up-regulation of TGF-beta mRNA in mononuclear cells. Ann NY Acad Sci 1996; 778:273-87.
19. 19 Xu LY, Huang YM, Yang JS, van der Meide PH, Levi M, Wahren B, Link H, Xiao BG. Dendritic cell-derived nitric oxide is involved in IL-4-induced suppression of experimental allergic encephalomyelitis in Lewis rats. Clin Exp Immunol 1999; 118:115-21.
20. 20 Eng LF, Ghirnikar RS, Lee YL. Inflammation in EAE: role of chemokine/cytokine expression by resident and infiltrating cells. Neurochem Res 1996; 21:511-25.
21. 21 Rocken M, Urban J, Shevach EM. Antigen-specific activation, tolerization, and reactivation of the interleukin 4 pathway in vivo. J Exp Med 1994; 179:1885-93.
22. 22 Kuchroo VK, Das MP, Brown JA et al. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 1995; 80:707-18.
23. 23 Lehmann PV, Sercarz EE, Forsthuber T, Dayan CM, Gammon G. Determinant spreading and the dynamics of the autoimmune T-cell repertoire. Immunol Today 1993; 14:203-8.